These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 7941331

  • 21. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
    Lin J, Johannsen E, Robertson E, Kieff E.
    J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
    Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E.
    J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
    Mannick JB, Cohen JI, Birkenbach M, Marchini A, Kieff E.
    J Virol; 1991 Dec; 65(12):6826-37. PubMed ID: 1658376
    [Abstract] [Full Text] [Related]

  • 26. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    Wang F, Tsang SF, Kurilla MG, Cohen JI, Kieff E.
    J Virol; 1990 Jul; 64(7):3407-16. PubMed ID: 2352328
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
    Tomkinson B, Robertson E, Kieff E.
    J Virol; 1993 Apr; 67(4):2014-25. PubMed ID: 8445720
    [Abstract] [Full Text] [Related]

  • 29. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F, Gregory CD, Rowe M, Rickinson AB, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E.
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.
    Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E.
    Proc Natl Acad Sci U S A; 1994 Aug 02; 91(16):7568-72. PubMed ID: 8052621
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
    Ling PD, Rawlins DR, Hayward SD.
    Proc Natl Acad Sci U S A; 1993 Oct 15; 90(20):9237-41. PubMed ID: 8415684
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation.
    Harada S, Kieff E.
    J Virol; 1997 Sep 15; 71(9):6611-8. PubMed ID: 9261383
    [Abstract] [Full Text] [Related]

  • 37. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN, Stewart JP, Janjua NJ, Pepper SD, Sample C, Rooney CM, Arrand JR.
    Virology; 1995 Apr 20; 208(2):521-30. PubMed ID: 7538250
    [Abstract] [Full Text] [Related]

  • 38. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines.
    Kempkes B, Zimber-Strobl U, Eissner G, Pawlita M, Falk M, Hammerschmidt W, Bornkamm GW.
    J Gen Virol; 1996 Feb 20; 77 ( Pt 2 )():227-37. PubMed ID: 8627226
    [Abstract] [Full Text] [Related]

  • 39. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
    Cohen JI, Picchio GR, Mosier DE.
    J Virol; 1992 Dec 20; 66(12):7555-9. PubMed ID: 1331538
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.